<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.949" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">471</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 292.300 L101.610 292.300 "/>
  <g begin="text">
   <text y="77.103" x="62.362,64.954,69.544,73.63,75.88,77.815,83.404,89.992,93.079,97.669,104.257,106.507,108.28,113.707,120.295,125.389,127.639,129.574,133.66,138.25,142.84,145.09,147.025,151.615,154.207,156.799,159.391,161.983,164.575,169.165,171.415,173.35,175.942,180.532,185.122,189.208,193.798,196.048,197.983,201.07,205.156,208.747,213.337,215.929,218.521,222.112,224.452,226.702,228.637,235.225,239.815,243.901,246.988,249.238,251.173,255.763,260.353,262.603,264.538,271.126,275.212,279.298,283.888,287.479,289.819,292.069,294.004,298.0" svgx:width="0.28,0.5,0.44,0.25,0.55,0.61,0.72,0.33,0.5,0.72,0.25,0.55,0.72,0.72,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.25,0.55,0.72,0.5,0.44,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.72,0.44,0.44,0.5,0.39,0.25,0.25,0.55,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the EQ-5D VAS and utility index results. Over 24 weeks, a </text>
   <text y="88.101" x="62.362,66.952,69.544,74.134,78.724,82.81,85.897,88.147,89.254,93.844,96.931,101.521,106.111,110.701,113.788,116.38,118.972,123.562,128.152,130.402,131.509,136.099,139.186,141.436,142.543,147.133,151.219,153.811,156.403,160.489,165.079,167.671,171.262,173.512,174.619,177.706,181.792,186.382,190.972,195.562,202.654,205.246,209.332,213.418,218.008,220.258,221.365,223.957,228.547,230.797,231.904,236.998,243.091,246.178,249.265,253.351,260.443,265.033,268.12,270.712,275.302,277.894,282.484,286.57,288.82,289.927,294.517,298.018" svgx:width="0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.44,0.5,0.5,0.5,0.78,0.28,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.56,0.67,0.33,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.55,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">higher proportion of patients randomized to PR-fampridine vs </text>
   <text y="99.099" x="62.362,66.952,69.544,73.63,77.716,81.802,86.392,90.982,93.205,97.291,101.881,106.471,110.557,113.644,116.236,120.322,124.912,128.998,133.084,137.674,139.897,143.983,146.575,149.167,153.757,156.349,160.435,164.521,167.113,169.705,174.295,176.518,183.61,187.696,191.782,196.372,198.964,203.554,208.144,211.231,215.821,218.413,220.636,223.228,230.32,234.91,237.997,242.587,247.177,251.263,258.355,262.441,267.031,269.623,273.214,275.437,280.027,284.617,286.84,289.432,294.022,298.018" svgx:width="0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.44,0.44,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.78,0.44,0.44,0.5,0.28,0.5,0.5,0.33,0.5,0.28,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.39,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">placebo experienced clinically meaningful improvements on the </text>
   <text y="110.097" x="62.362,70.453,75.547,84.133,89.227,92.314,96.904,101.494,103.744,106.138,109.225,114.256,118.846,121.096,123.49,128.08,132.67,135.262,139.852,142.444,144.694,147.088,154.18,158.266,162.352,166.942,169.192,171.586,174.178,181.27,185.86,188.947,193.537,198.127,202.213,209.305,213.391,217.981,220.573,223.66,226.252,228.502,230.896,235.486,240.076,242.416,247.006,254.593,256.84299999999996,259.237,263.827,267.418,269.758,272.008,274.402,278.992,283.582,285.922,290.512,298.009" svgx:width="0.89,0.56,0.94,0.56,0.33,0.5,0.5,0.25,0.55,0.33,0.55,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.28,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.33,0.28,0.25,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.5,0.39,0.25,0.25,0.55,0.5,0.5,0.25,0.5,0.83,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MSWS-12 (≥8 point mean improvement): 48.5% vs. 28.1% </text>
   <text y="121.095" x="62.362" svgx:width="0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(</text>
   <text y="121.095" x="65.449" svgx:width="0.61" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">P</text>
   <text y="121.095" x="71.038,76.204,80.794,83.134,87.724,92.314,96.904,99.991,102.583,105.382,109.468,114.058,118.648,121.285,126.874,133.462,140.05,142.849,146.44,151.03,155.116,159.202,163.792,166.591,169.678,174.709,179.299,183.889,191.476,194.275,201.367,205.453,209.539,214.129,216.928,219.52,226.612,231.202,234.289,238.879,243.469,247.555,254.647,258.733,263.323,265.915,269.002,271.594,274.393,278.983,283.573,285.913,290.503,298.0" svgx:width="0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.28,0.25,0.44,0.5,0.5,0.25,0.61,0.72,0.72,0.25,0.39,0.5,0.44,0.44,0.5,0.25,0.33,0.55,0.5,0.5,0.83,0.25,0.78,0.44,0.44,0.5,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.33,0.28,0.25,0.5,0.5,0.25,0.5,0.83,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">=0.015); and TUG speed (≥15% mean improvement): 47.1% </text>
   <text y="132.093" x="62.362,66.952,70.543,72.883,75.457,80.047,84.637,86.977,91.567,99.154,101.728" svgx:width="0.5,0.39,0.25,0.25,0.5,0.5,0.25,0.5,0.83,0.25,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">vs. 30.2% (</text>
   <text y="132.093" x="104.815" svgx:width="0.61" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">P</text>
   <text y="132.093" x="110.395,115.561,120.151,122.491,127.081,131.671,136.261,139.348,141.688,144.262,147.349,151.435,155.026,159.616,163.702,167.788,170.38,172.972,177.562,181.648,184.24,188.245,190.585,193.159,198.253,202.339,205.426,209.512,212.104,216.694,219.268,222.355,224.947,229.537,234.127,236.719,241.309,245.899,249.49,252.064,258.652,262.738,265.825,269.911,272.485,276.076,278.668,285.76,288.352,290.944,295.03,298.027" svgx:width="0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.25,0.56,0.44,0.33,0.44,0.28,0.5,0.25,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">=0.026), respectively. Safety findings were similar </text>
   <text y="143.091" x="62.362,64.954,69.544,71.884,76.474,81.064,84.655,87.247,90.334,97.426,101.512,104.599,109.189,113.275,115.867,118.459,123.049,127.639,129.979,134.065,138.655,143.245,147.331,150.418,153.01,157.096,161.686,165.772,169.858" svgx:width="0.28,0.5,0.25,0.5,0.5,0.39,0.28,0.33,0.78,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to post-marketing experience.</text>
   <text y="154.089" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="154.089" x="113.68,118.684,124.687,127.684,130.681,134.677,141.679,146.179,149.176,151.678,156.178,158.68,163.18,167.176,168.985,171.487,174.484,178.48,182.476,184.978,191.98,195.976,200.476,202.978,204.787,209.287,212.788,214.597,219.097,221.599,225.595,229.591,233.587,238.087,242.587,244.396,247.393,251.389,254.89,259.39,261.892,264.394,268.39,272.89,274.699,277.201,281.701,283.51,287.011,291.511,295.012" svgx:width="0.56,0.67,0.33,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.39,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.39,0.5,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PR-fampridine treatment vs placebo resulted in sus-</text>
   <text y="165.087" x="62.362,64.864,68.86,71.362,75.862,79.858,84.358,86.608,87.373,89.875,96.877,101.377,104.374,108.874,113.374,117.37,124.372,128.368,132.868,135.37,138.871,141.121,141.886,144.388,148.888,151.138,151.912,158.41,162.406,164.908,169.408,171.91,176.41,180.91,183.16,185.41,186.175,190.675,194.671,197.173,201.169,205.669,209.665,213.661,215.911,218.161,218.926,222.922,227.422,231.922,234.172,234.937,237.439,244.441,248.941,252.937,256.933,259.435,261.685,262.45,266.95,269.947,272.197,272.971,280.972,285.976,288.226,288.991,293.491,297.991" svgx:width="0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tained improvements in walking, balance, and impact of MS on </text>
   <text y="176.085" x="62.362,64.864,69.364,73.36,75.169,79.669,83.665,86.167,88.669,92.665,97.165,99.667,102.169,103.978,106.48,110.98,114.976,118.477,122.473,124.282,128.782,132.778,137.278,141.274,144.271,146.773,149.275,152.776,154.585,161.083,165.079,168.076,172.072,173.881,177.877,182.377,186.877,190.873,193.87,197.866,202.366,204.868,206.677,210.673,213.175,214.822,222.598,226.594,230.59,235.09,236.899,241.399,243.208,247.204,251.704,256.204,258.013,265.015,269.011,271.513,276.013,278.515,282.511,285.013,289.513,293.509,298.009" svgx:width="0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.28,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.44,0.5,0.44,0.33,0.28,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.5,0.44,0.33,0.44,0.5,0.28,0.25,0.44,0.28,0.25,0.94,0.44,0.44,0.5,0.25,0.5,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.28,0.5,0.28,0.44,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the patient; these benefits were apparent at Week 2 and maintained </text>
   <text y="187.083" x="62.362,64.864,69.364,72.361,76.861,81.361,85.861,90.361,94.861,99.361,101.863,104.743,107.245,111.745,115.741,118.621,123.121,127.621,130.618,137.116,141.112,145.108,149.608,152.488,154.99,157.987,161.983,165.979,168.481,175.483,179.479,183.979,186.481,189.361,193.861,197.857,200.854,203.356,207.856,212.356,215.236,219.736,224.236,226.738,229.24,231.742,234.622,237.124,240.121,244.117,248.113,250.615,257.617,261.613,266.113,268.615,271.495,275.995,278.497,281.998,285.994,290.494,294.994" svgx:width="0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.5,0.5,0.28,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.33,0.72,0.44,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.5,0.5,0.28,0.28,0.28,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.28,0.39,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">throughout the 24-week treatment period until treatment discon-</text>
   <text y="198.081" x="62.362,64.864,67.366,71.866,76.366,80.362,82.864,85.366,89.866,94.366,96.616,98.866,101.548,107.047,111.547,115.543,119.044,123.04,125.29,128.134,131.131,133.633,138.133,142.633,145.135,149.635,154.135,157.636,159.886,162.73,167.23,171.226,178.228,182.728,187.228,190.729,193.231,196.228,200.224,202.726,206.722,211.222,213.472,216.316,220.312,224.812,229.312,231.814,234.316,236.818,241.318,245.818,249.814,252.316,254.566,257.41,261.91,265.906,270.406,274.402,277.399,279.901,282.403,285.904,288.154,290.998,293.5,298.0" svgx:width="0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.39,0.44,0.25,0.55,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.39,0.25,0.55,0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.5,0.44,0.5,0.44,0.33,0.28,0.28,0.39,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tinuation. These findings demonstrated additional benefits to </text>
   <text y="209.079" x="62.362,64.864,69.364,73.864,77.365,81.361,83.728,88.228,91.225,93.592,96.094,100.594,104.59,106.957,111.961,116.461,120.457,123.958,127.954,130.321,134.821,137.188,140.689,143.191,147.691,152.191,154.693,158.689,162.19,164.44,166.807,173.305,175.807,178.309,182.809,185.176,189.172,191.539,194.041,198.541,203.041,207.541,211.537,214.534,216.901,219.403,222.4,226.396,230.392,232.894,239.896,243.892,248.392,250.894,253.261,257.761,261.757,264.754,267.256,271.756,276.256,278.623,282.619,287.119,291.619,293.986,297.982" svgx:width="0.28,0.5,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.56,0.5,0.44,0.39,0.44,0.25,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.28,0.5,0.5,0.5,0.44,0.33,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">those of the Phase 3 studies, with a longer treatment period and a </text>
   <text y="220.077" x="62.362,66.862,69.859,74.359,78.355,82.855,86.851,89.848,91.81,94.807,98.803,103.303,107.803,111.799,113.761,118.261,121.258,123.22,127.72,132.22,134.722,138.718,142.714,145.216,147.718,152.218,156.214,158.176,162.172,166.672,171.172,173.134,177.634,181.63,184.132,186.634,190.63,195.13,197.632,200.629,203.626,207.622,212.122,216.622,219.619,222.121,226.117,230.617,232.579,239.581,243.577,247.573,251.074,255.574,258.571,262.567,266.068,268.03,272.53,275.527,277.489,283.987,287.983,290.485,294.985" svgx:width="0.5,0.33,0.5,0.44,0.5,0.44,0.33,0.25,0.33,0.44,0.5,0.5,0.44,0.25,0.5,0.33,0.25,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.33,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.39,0.25,0.5,0.33,0.25,0.72,0.44,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">broader range of objective and patient-reported measures of walk-</text>
   <text y="231.075" x="62.362,64.864,69.364,73.864,76.114,80.11,84.61,87.112,89.614,92.116,94.618,99.118,101.368,105.364,109.864,114.364,116.614,121.114,125.11,127.612,131.608,136.108,140.104,144.1" svgx:width="0.28,0.5,0.5,0.25,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing ability and balance.</text>
   <text y="258.075" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P923</text>
   <text y="269.073" x="62.362,68.365,73.369,77.365,79.615,83.611,86.608,89.605,93.601,97.597,100.594,103.096,107.596,111.592,116.596,120.592,124.093,127.594,129.844,134.344,139.348,144.352,146.602,150.103,154.603,157.6,161.596,164.593,169.093,171.343,175.843,178.84,181.09,184.087,189.091,193.087,195.337,197.839,202.843,205.84,209.836,214.336,217.333,222.337,226.333,230.329,234.829,237.331,239.581,244.585,249.085,253.081,255.583,260.083,263.08,267.076,272.08" svgx:width="0.67,0.56,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.56,0.44,0.39,0.39,0.25,0.5,0.56,0.56,0.25,0.39,0.5,0.33,0.44,0.33,0.5,0.25,0.5,0.33,0.25,0.33,0.56,0.44,0.25,0.28,0.56,0.33,0.44,0.5,0.33,0.56,0.44,0.44,0.5,0.28,0.25,0.56,0.5,0.44,0.28,0.5,0.33,0.44,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">The effectiveness and safety of the intrathecal baclofen </text>
   <text y="280.071" x="62.362,65.359,69.859,73.855,76.105,79.102,84.106,88.102,90.352,97.849,102.853,105.355,108.352,110.854,115.858,118.36,122.356,124.606,128.107,132.103,134.605,138.601,142.597,147.097,150.598,153.1,156.601,159.598,163.594,167.59,170.092,174.592,177.589,181.585,186.589,188.839,192.34,197.344,201.844,205.345,208.342,210.844,214.84,217.342,220.339" svgx:width="0.33,0.5,0.44,0.25,0.33,0.56,0.44,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.33,0.44,0.44,0.28,0.5,0.33,0.44,0.56,0.25,0.39,0.56,0.5,0.39,0.33,0.28,0.44,0.28,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">for the multiple sclerosis-related spasticity</text>
   <text y="291.069" x="62.362,67.366,69.616,76.114,80.11,82.612,86.608,91.108,95.608,98.11" svgx:width="0.56,0.25,0.72,0.44,0.28,0.44,0.5,0.5,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">S Gatzonis</text>
   <text y="288.583" x="101.611" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="291.103" x="104.536,106.786,109.036,115.534,117.784,125.785,129.781,132.778,137.278,141.274,143.776,146.278" svgx:width="0.25,0.25,0.72,0.25,0.89,0.44,0.33,0.5,0.44,0.28,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, K Margetis</text>
   <text y="288.583" x="149.778" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="291.103" x="152.703,154.953,157.203,163.701,165.951,171.954,176.454,180.954,183.456,187.956" svgx:width="0.25,0.25,0.72,0.25,0.67,0.5,0.5,0.28,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, N Boutos</text>
   <text y="288.583" x="191.457" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="291.103" x="194.382,196.632,198.882,205.38,207.63,212.634,215.136,219.132,221.634,226.134,230.634,235.134" svgx:width="0.25,0.25,0.72,0.25,0.56,0.28,0.44,0.28,0.5,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Siatouni</text>
   <text y="288.583" x="237.636" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="291.103" x="240.561,242.811,245.061,250.56" svgx:width="0.25,0.25,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, E </text>
   <text y="302.101" x="62.361,68.364,72.864,77.364,79.866,83.862,86.364,89.865,92.367" svgx:width="0.67,0.5,0.5,0.28,0.44,0.28,0.39,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Boviatsis</text>
   <text y="299.583" x="95.869" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="302.103" x="98.794,101.044,103.294,109.792,115.291,117.541,122.545,126.541,131.041,135.037" svgx:width="0.25,0.25,0.72,0.61,0.25,0.56,0.44,0.5,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, DE Sakas</text>
   <text y="299.583" x="138.537" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="310.581" x="62.364" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="313.103" x="65.287,70.786,73.288,77.788,81.784,86.284,89.785,92.035,99.532,103.528,108.028,110.53,114.526,119.026,121.528,123.778,128.278,132.274,136.774,141.274,145.774,148.276,150.526,152.776,158.275,161.272,163.522,169.525,173.521,178.021,181.522,186.022,189.523,194.023,197.524,202.024,206.02,209.521,213.517,215.767,222.265,226.261,230.761,235.261,238.762,241.264,247.762,251.758,256.258,258.76,261.01,263.26,268.759,271.261,275.761,279.757,284.257,287.758,290.008" svgx:width="0.61,0.28,0.5,0.44,0.5,0.39,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.5,0.44,0.5,0.5,0.5,0.28,0.25,0.25,0.61,0.33,0.25,0.67,0.44,0.5,0.39,0.5,0.39,0.5,0.39,0.5,0.44,0.39,0.44,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.25,0.61,0.28,0.5,0.44,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Athens Medical School, A’ Neurosurgery Department, Athens, </text>
   <text y="324.101" x="62.362,68.86,72.361,76.357,80.353,84.349" svgx:width="0.72,0.39,0.44,0.44,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Greece</text>
   <text y="351.101" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="351.101" x="114.679,122.68,127.18,129.682,132.184,134.686,139.186,141.688,145.684,147.655,151.156,155.152,157.654,161.65,164.647,169.147,172.648,175.15,178.651,180.622,183.619,191.62,196.624,199.621,201.592,206.092,210.088,212.59,215.092,219.088,223.588,226.09,229.591,231.562,238.564,242.56,247.06,249.031,253.531,257.527,262.027,266.023,268.525,273.025,277.525,279.496,282.997,287.497,291.493,294.994" svgx:width="0.89,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.78,0.44,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.25,0.39,0.5,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Multiple sclerosis (MS) patients may develop spas-</text>
   <text y="362.099" x="62.362,64.864,67.366,71.362,73.864,76.366,80.866,83.116,85.096,89.596,94.096,97.093,99.595,104.095,108.595,110.845,112.825,115.327,119.827,123.823,126.073,128.053,132.049,136.549,141.049,144.046,147.547,151.543,153.793,155.773,160.273,163.27,165.52,167.5,170.002,174.502,178.498,181.0,183.997,186.247,188.227,192.727,195.229,198.73,202.726,206.722,210.223,214.219,216.469,218.719,220.537,226.036,230.536,234.532,236.782,238.762,242.263,246.763,250.759,254.26,256.762,259.264,263.26,265.762,268.264,272.764,275.014,276.994,283.996,286.498,290.998,295.498,298.0" svgx:width="0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.55,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.28,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.39,0.5,0.44,0.39,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.55,0.78,0.28,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ticity during the course of their disease. The spasticity might </text>
   <text y="373.097" x="62.362,64.864,71.866,76.366,80.866,84.367,88.363,90.613,92.386,96.886,100.882,107.38,109.63,111.403,114.4,118.9,123.4,127.396,129.898,132.4,136.9,141.4,145.396,147.898,150.148,151.921,154.423,156.925,163.927,166.429,168.931,172.927,175.429,177.931,182.431,186.931,190.432,192.682,194.455,198.955,203.455,205.705,207.478,209.98,214.48,218.476,220.726,222.499,226.999,230.995,233.497,235.999,239.995,244.495,246.997,250.498,252.748,254.521,258.517,263.017,267.517,269.767,271.54,274.042,281.044,285.544,289.54,294.04,298.036" svgx:width="0.28,0.78,0.5,0.5,0.39,0.44,0.25,0.55,0.5,0.44,0.72,0.25,0.55,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.28,0.28,0.78,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.78,0.5,0.44,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">impose new functional limitations on the patients and impede </text>
   <text y="384.095" x="62.362,64.864,69.364,73.36,75.862,78.859,81.109,85.105,89.101,92.098,96.094" svgx:width="0.28,0.5,0.44,0.28,0.33,0.25,0.44,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">their care.</text>
   <text y="395.093" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="395.093" x="108.397,116.173,120.169,122.716,126.712,129.214,136.216,138.763,141.265,145.765,148.312,152.812,155.809,159.805,163.306,167.302,171.802,174.304,176.851,181.351,185.851,188.848,191.395,195.895,200.395,203.392,207.892,211.888,215.884,218.881,221.428,225.424,229.924,234.424,238.42,241.417,243.919,247.915,252.415,256.411,260.407,262.954,267.454,271.954,274.501,277.003,284.005,288.505,291.007,295.003" svgx:width="0.94,0.44,0.25,0.44,0.28,0.78,0.25,0.28,0.5,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.5,0.5,0.33,0.25,0.5,0.5,0.33,0.5,0.44,0.44,0.33,0.25,0.44,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.44,0.44,0.25,0.5,0.5,0.25,0.28,0.78,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We aim to present our 14-year experience on imple-</text>
   <text y="406.091" x="62.362,69.364,73.36,77.86,80.362,82.864,87.364,91.864,94.114,95.329,97.831,102.331,106.327,108.577,109.792,112.294,116.794,119.296,122.293,126.289,128.791,133.291,137.287,141.283,145.279,147.781,150.031,151.246,155.746,159.742,163.738,166.24,170.74,173.737,177.733,182.233,184.483,185.698,188.2,192.7,196.696,199.693,203.689,208.189,212.689,214.939,216.154,219.151,222.148,227.647,233.65,236.647,238.897,240.112,243.109,247.609,250.606,252.856,254.071,256.573,261.073,265.069,267.319,268.534,272.035,276.535,283.537,288.037,290.539,295.039" svgx:width="0.78,0.44,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.28,0.33,0.44,0.28,0.5,0.44,0.44,0.44,0.28,0.25,0.55,0.5,0.44,0.44,0.28,0.5,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.55,0.33,0.33,0.61,0.67,0.33,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.5,0.78,0.5,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">menting the intrathecal baclofen therapy (ITB) for the sympto-</text>
   <text y="417.089" x="62.362,69.364,73.36,75.862,78.364,82.36,84.61,87.112,90.109,94.105,98.101,100.603,107.605,111.601,116.101,118.603,120.853,125.353,128.35,130.6,134.101,138.601,142.597,146.098,148.6,151.102,155.098,157.6,160.102,164.602,166.852,169.354,173.854,176.104,184.105,189.109,191.359,195.859,199.855,202.357,204.859,208.855,213.355,215.857,219.358" svgx:width="0.78,0.44,0.28,0.28,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.39,0.5,0.44,0.39,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">matic treatment of spasticity in MS patients.</text>
   <text y="428.087" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="428.087" x="101.602,107.605,110.35,113.347,117.343,119.845,122.842,127.342,130.843,135.343,139.339,143.335,145.837,148.339,152.839,156.835,159.571,163.072,165.574,170.074,174.574,179.074,181.81,188.308,192.304,195.805,198.55,202.546,207.046,211.546,216.046,220.546,224.542,227.044,231.04,235.54,238.276,242.272,244.774,247.519,253.018,257.518,261.514,266.014,270.514,274.51,277.012,279.514,283.015,290.017,294.517,298.018" svgx:width="0.72,0.25,0.33,0.44,0.28,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.5,0.5,0.5,0.44,0.28,0.44,0.5,0.25,0.44,0.28,0.25,0.61,0.5,0.44,0.5,0.5,0.44,0.28,0.28,0.39,0.78,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A retrospective study was conducted at Evangelismos </text>
   <text y="439.085" x="62.362,68.86,73.36,76.861,81.361,83.863,86.365,90.361,92.863,95.113,96.733,99.235,103.735,105.985,107.605,111.601,116.101,119.098,123.598,126.1,128.602,130.852,132.472,140.473,145.477,147.727,149.347,153.847,157.843,160.345,162.847,166.843,171.343,173.845,177.346,179.596,181.216,187.714,192.214,196.714,198.964,200.584,205.084,209.08,213.58,215.83,217.45,221.95,226.45,230.95,234.946,237.781,242.281,246.781,251.281,255.277,257.527,259.147,262.144,267.643,273.646,275.896,277.516,282.016,286.516,293.518,298.018" svgx:width="0.72,0.5,0.39,0.5,0.28,0.28,0.44,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.33,0.5,0.28,0.28,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.5,0.44,0.33,0.5,0.5,0.5,0.44,0.25,0.55,0.33,0.61,0.67,0.25,0.55,0.5,0.5,0.78,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Hospital to enroll MS patients who had undergone ITB pump </text>
   <text y="450.083" x="62.362,64.864,71.866,76.366,78.868,82.864,87.364,89.866,93.862,96.364,98.866,103.366,107.866,110.206,113.203,116.2,120.7,127.702,130.042,134.542,139.042,143.542,148.042,150.382,152.884,157.384,159.724,164.224,168.724,173.224,177.724,179.974,182.314,190.315,195.319,197.659,202.159,206.155,208.657,211.159,215.155,219.655,222.157,225.658,227.998,234.496,238.996,243.496,245.836,250.336,254.332,258.832,261.172,264.169,268.165,270.667,273.169,277.165,281.665,284.005,288.505,291.502,295.498,298.0" svgx:width="0.28,0.78,0.5,0.28,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.5,0.5,0.25,0.5,0.44,0.5,0.25,0.33,0.44,0.28,0.28,0.44,0.5,0.25,0.5,0.33,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">implantation from 2000 to 2013. MS patients who had failed oral </text>
   <text y="461.081" x="62.362,66.358,70.858,73.36,75.862,78.859,82.36,86.86,90.856,94.357,96.859,99.361,103.357,105.859,108.361,112.861,115.111,117.415,119.917,122.914,126.91,130.906,133.408,140.41,144.406,148.906,151.408,153.658,155.962,158.959,163.459,167.959,171.955,174.205,176.509,179.011,183.511,185.761,188.065,192.565,197.065,201.565,205.561,209.062,211.564,214.561,218.557,223.057,225.307,227.611,231.112,233.614,238.114,242.11,244.36,246.664,250.66,253.495,256.492,260.488,264.484,266.986,270.487,272.737,275.041,279.037,283.537,288.037,290.539,295.039,298.036" svgx:width="0.44,0.5,0.28,0.28,0.33,0.39,0.5,0.44,0.39,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.33,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.5,0.44,0.39,0.28,0.33,0.44,0.5,0.25,0.55,0.39,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.28,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">anti-spasticity treatment (due to undesired side effects and/or </text>
   <text y="472.079" x="62.362,66.862,71.362,74.863,78.859,81.361,83.863,87.364,90.361,94.357,98.353,100.855,105.355,108.352,112.852,115.102,116.623,120.619,125.119,129.619,132.121,135.118,139.618,142.12,144.37,145.891,150.391,153.388,155.638,157.159,159.661,164.161,168.157,170.659,173.656,175.906,177.427,180.928,185.428,189.424,192.925,195.427,197.929,201.925,204.427,206.929,211.429,214.426,216.676,218.197,224.695,228.691,231.688,235.684,237.934,239.455,242.956,247.456,251.956,258.958,261.46,263.962,266.464,270.46,274.96,277.21,278.731,281.233,285.733,287.983,289.504,293.5,298.0" svgx:width="0.5,0.5,0.39,0.44,0.28,0.28,0.39,0.33,0.44,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.28,0.33,0.25,0.55,0.39,0.5,0.44,0.39,0.28,0.28,0.44,0.28,0.28,0.5,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.5,0.5,0.78,0.28,0.28,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">unsatisfactory control of their spasticity) were submitted to an </text>
   <text y="483.077" x="62.362,64.864,69.364,71.866,74.863,78.859,81.361,85.861,89.857,93.853,97.849,100.351,102.601,104.68,107.182,110.179,112.681,116.677,119.179,121.429,123.508,126.01,130.51,133.012,137.008,141.004,143.506,146.008,150.508,155.008,157.258,159.337,163.837,166.834,169.084,171.163,175.663,180.163,187.165,191.161,195.661,197.911,199.99,204.49,208.486,212.482,214.984,219.484,222.481,226.477,230.977,233.227,235.477,237.061,243.064,245.314,247.393,251.893,256.393,263.395,267.895,270.145,272.224,275.221,279.721,282.718,284.968,287.047,289.549,294.049,298.045" svgx:width="0.28,0.5,0.28,0.33,0.44,0.28,0.5,0.44,0.44,0.44,0.28,0.25,0.55,0.28,0.33,0.28,0.44,0.28,0.25,0.55,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.44,0.44,0.28,0.5,0.33,0.44,0.5,0.25,0.25,0.55,0.72,0.25,0.55,0.5,0.5,0.78,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">intrathecal trial injection of 50mcg baclofen. A pump for the </text>
   <text y="494.075" x="62.362,64.864,69.364,71.866,74.863,78.859,81.361,85.861,89.857,93.853,97.849,100.351,102.601,105.949,109.945,114.445,121.447,123.949,128.449,130.951,134.452,136.954,139.951,143.947,146.449,148.951,153.451,157.951,160.201,163.549,168.049,171.046,173.296,176.644,181.144,185.14,189.136,191.638,196.138,199.135,203.131,207.631,209.881,213.229,219.727,223.723,227.224,229.474,232.822,235.324,242.326,246.826,249.328,253.324,257.824,260.326,264.322,268.822,271.072,274.42,276.922,281.422,283.672,287.02,289.522,294.022,298.018" svgx:width="0.28,0.5,0.28,0.33,0.44,0.28,0.5,0.44,0.44,0.44,0.28,0.25,0.55,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.44,0.28,0.5,0.33,0.44,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.78,0.5,0.28,0.44,0.5,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">intrathecal administration of baclofen was implanted to the </text>
   <text y="505.073" x="62.362,66.862,70.858,73.36,75.862,79.858,84.358,86.86,90.361,92.611,98.209,104.707,109.207,113.707,115.957,121.555,124.552,128.548,132.049,136.549,141.049,145.549,150.049,154.045,158.545,160.795,166.393,169.39,173.386,177.886,182.386,185.383,189.379,193.879,196.381,200.881,203.131,208.729,211.231,215.731,217.981,223.579,226.081,230.581,234.577,236.827,242.425,246.925,250.921,254.917,257.419,261.919,264.916,268.912,273.412,275.662,281.26,283.762,286.759,289.261,293.257,295.759,298.009" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.33,0.44,0.5,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.44,0.28,0.5,0.33,0.44,0.5,0.25,0.55,0.28,0.33,0.28,0.44,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients who responded favorably to the baclofen trial. </text>
   <text y="516.071" x="62.362,65.359,73.36,77.356,81.856,85.357,87.859,90.856,94.852,98.848,105.85,108.1,110.35,116.236,122.734,126.73,131.23,135.73,140.23,142.48,148.366,153.37,157.87,162.37,164.872,169.372,173.368,176.869,179.371,181.621,187.507,192.511,197.011,201.511,205.507,210.007,213.004,217.504,224.506,228.502,233.002,235.252,241.138,244.135,247.132,249.382,251.632,257.518,265.519,269.515,274.015,276.517,279.514,284.014,288.514,291.016,295.012,298.009" svgx:width="0.33,0.89,0.44,0.5,0.39,0.28,0.33,0.44,0.44,0.78,0.25,0.25,0.55,0.72,0.44,0.5,0.5,0.5,0.25,0.55,0.56,0.5,0.5,0.28,0.5,0.44,0.39,0.28,0.25,0.55,0.56,0.5,0.5,0.44,0.5,0.33,0.5,0.78,0.44,0.5,0.25,0.55,0.33,0.33,0.25,0.25,0.55,0.89,0.44,0.5,0.28,0.33,0.5,0.5,0.28,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(Medstream, Depuy Synthes; Synchromed II, Medtronic) </text>
   <text y="527.069" x="62.362,65.359,71.857,74.854,78.85,83.35,85.852,92.854,96.85,101.35,105.346,108.847,111.097,113.347,119.35,123.85,128.35,135.352,139.348,143.848,146.35,148.6,151.597,156.268,158.518,163.018,167.518,172.018,176.518,178.606,183.943,186.193,188.281,193.465,196.462,198.964,202.96,207.46,214.462,218.458,222.958,225.955" svgx:width="0.33,0.72,0.33,0.44,0.5,0.28,0.78,0.44,0.5,0.44,0.39,0.25,0.25,0.67,0.5,0.5,0.78,0.44,0.5,0.28,0.25,0.33,0.56,0.25,0.5,0.5,0.5,0.5,0.25,0.72,0.25,0.25,0.61,0.33,0.28,0.44,0.5,0.78,0.44,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(Archimedes, Codman; IP 2000 V, Tricumed).</text>
   <text y="538.067" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="538.067" x="99.631,105.13,109.63,112.132,115.129,117.631,122.131,124.381,128.404,132.904,136.9,139.402,141.904,145.9,150.4,152.902,156.403,158.653,162.676,165.673,170.173,174.673,178.957,181.207,183.457,187.48,191.647,196.147,204.148,207.145,209.395,213.418,219.916,222.418,224.92,229.42,231.67,235.693,239.689,241.939,245.962,252.964,256.96,260.956,265.456,267.706,271.729,275.725,280.225,284.221,286.471,290.494,294.994,297.991" svgx:width="0.61,0.5,0.28,0.33,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.5,0.56,0.25,0.25,0.55,0.5,0.5,0.89,0.33,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Thirty patients (19F, 11M) with a mean age of </text>
   <text y="549.065" x="62.362,66.862,71.362,73.612,78.112,83.053,87.553,89.803,94.303,98.803,103.303,107.803,109.972,112.969,115.966,119.962,124.462,128.962,132.958,135.46,139.96,144.46,147.457,151.957,156.457,159.454,161.623,168.121,172.117,175.114,179.11,181.279,185.275,189.775,192.772,197.272,199.774,202.276,206.272,210.772,213.022,215.029,220.528,225.028,229.024,231.193,238.195,242.191,246.187,250.687,252.856,257.356,260.353,264.349,267.346,271.846,276.346,278.515,286.516,293.014,298.018" svgx:width="0.5,0.5,0.25,0.5,0.55,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.33,0.5,0.5,0.33,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.5,0.33,0.44,0.33,0.5,0.5,0.25,0.89,0.72,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">47.8±9.79yo (range:23-65) were enrolled. The mean pre-op MAS </text>
   <text y="560.063" x="62.362,65.359,73.36,77.86,82.36,84.862,87.859,90.361,94.357,98.857,101.332,107.83,111.331,115.831,122.329,126.829,129.826,132.328,136.828,139.078,139.798,144.802,148.798,152.794,155.296,159.292,162.289,164.539,165.259,171.757,175.753,179.254,181.504,182.224,186.724,188.974,193.474,197.974,200.224,200.944,203.941,206.938,210.934,215.434,219.934,223.93,226.18,226.9,231.4,234.397,238.897,241.894,244.144,246.394,247.114,249.616,254.116,258.112,260.362,261.082,268.084,272.08,276.076,280.576,282.826,283.546,288.046,292.042,295.543,298.045" svgx:width="0.33,0.89,0.5,0.5,0.28,0.33,0.28,0.44,0.5,0.25,0.72,0.39,0.5,0.72,0.5,0.33,0.28,0.5,0.25,0.55,0.56,0.44,0.44,0.28,0.44,0.33,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.25,0.5,0.5,0.25,0.55,0.33,0.33,0.44,0.5,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.33,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.5,0.44,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(Modified Ashworth Scale) was 2.86 (range 2-4), the mean best </text>
   <text y="571.061" x="62.362,70.363,76.861,81.865,84.115,88.111,91.108,93.61,97.606,100.603,102.853,105.355,109.855,113.851,116.101,120.601,124.597,128.593,131.095,135.595,138.592,142.588,147.088,149.338,151.84,154.837,157.339,161.335,163.837,166.087,172.585,176.581,180.082,182.332,186.832,189.082,193.582,198.082" svgx:width="0.89,0.72,0.56,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.44,0.28,0.5,0.33,0.44,0.5,0.25,0.28,0.33,0.28,0.44,0.28,0.25,0.72,0.44,0.39,0.25,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MAS after the baclofen trial was 1.18.</text>
   <text y="582.059" x="74.359,80.992,85.123,87.76,91.891,94.141,94.834,99.469,102.601,106.732,110.368,114.499,119.134,121.771,125.902,130.537,132.787,133.48,138.115,142.246,145.378,149.509,151.759,152.452,156.583,161.218,165.853,169.984,174.115,177.247,181.882,184.132,184.825,189.46,194.095,196.345,197.038,201.673,205.804,208.441,211.078,215.209,219.844,222.481,226.117,228.367,229.06,235.693,240.328,244.963,247.213,247.906,251.038,255.673,258.31,261.442,264.079,266.716,269.353,271.603,272.296,276.427,279.064,281.701,283.951,284.644,287.776,292.411,295.048" svgx:width="0.72,0.44,0.28,0.44,0.25,0.55,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.5,0.44,0.44,0.33,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.33,0.5,0.28,0.33,0.28,0.28,0.28,0.25,0.55,0.44,0.28,0.28,0.25,0.55,0.33,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Data presented here concern 14 patients who fulfill all fol-</text>
   <text y="593.057" x="62.362,64.999,69.634,76.267,79.399,84.034,88.669,90.919,91.603,95.734,98.866,101.503,104.14,108.271,111.403,114.04,118.171,120.556,123.328,128.962,133.597,137.728,139.978,140.662,147.799,151.93,156.061,160.696,162.946,163.63,168.265,172.9,176.536,179.173,182.305,186.94,191.575,193.825,194.509,202.645,209.278,214.417,216.667,217.351,223.984,228.115,231.751,234.001,234.685,239.32,241.705,246.34,250.975,255.61,257.995,260.767,266.401,271.036,275.167,277.417,278.101,285.238,289.369,293.5,298.0" svgx:width="0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.55,0.44,0.33,0.28,0.28,0.44,0.33,0.28,0.44,0.25,0.25,0.61,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.5,0.5,0.39,0.28,0.33,0.5,0.5,0.25,0.55,0.89,0.72,0.56,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.25,0.5,0.5,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">low-up criteria. The mean post-op MAS was 0.375. The mean </text>
   <text y="604.055" x="62.362,65.494,68.131,72.766,76.897,79.534,81.838,86.473,90.604,94.735,97.372,102.007,105.139,109.27,113.905,116.209,120.844,125.479,129.115,133.246,135.55,142.183,146.314,149.95,152.254,156.889,161.524,166.159,168.463,175.6,179.731,184.366,187.003,191.638,196.273,200.908,203.212,206.344,209.476,213.607,218.242,222.877,227.008,229.645,231.949,236.584,241.219,244.351,248.986,253.621,258.256,261.388,263.773,265.582,272.215,276.85,279.154,283.285,287.92,292.051,295.021" svgx:width="0.33,0.28,0.5,0.44,0.28,0.25,0.5,0.44,0.44,0.28,0.5,0.33,0.44,0.5,0.25,0.5,0.5,0.39,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.5,0.25,0.78,0.44,0.5,0.28,0.5,0.5,0.5,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.28,0.25,0.5,0.5,0.33,0.5,0.5,0.5,0.33,0.25,0.25,0.72,0.5,0.25,0.44,0.5,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">final baclofen dose was 104 mcg/24h (range: 30-320). An aver-</text>
   <text y="615.053" x="62.362,66.493,71.128,75.259,77.752,82.387,85.519,88.012,92.647,95.032,99.667,102.16,106.795,111.43,115.066,119.197,121.69,125.821,130.456,133.093,137.728,141.364,144.001,151.138,155.269,159.904,162.541,166.177,168.67,175.303,179.434,182.566,186.697,189.19,192.322,196.453,201.088,205.723,208.36,211.492,215.623,220.258,222.751,225.388,230.023,232.516,236.647,240.778,245.413,248.05,252.181,256.816,260.947,263.44,267.571,270.064,273.196,277.327,279.964,284.095,286.732,289.369,294.004,298.0" svgx:width="0.44,0.5,0.44,0.25,0.5,0.33,0.25,0.5,0.25,0.5,0.25,0.5,0.5,0.39,0.44,0.25,0.44,0.5,0.28,0.5,0.39,0.28,0.78,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.33,0.44,0.5,0.5,0.28,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.44,0.5,0.28,0.44,0.5,0.44,0.25,0.44,0.25,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">age of 5.7 dose adjustments were required to achieve a relative </text>
   <text y="626.051" x="62.362,65.998,68.635,72.766,77.401,80.038,84.169,86.662,91.297,95.932,99.568,103.699,106.084,108.577,115.21,119.845,123.976,126.469,131.104,135.235,137.872,140.509,144.64,149.275,151.912,154.405,159.04,161.677,165.808,170.443,172.936,177.571,182.206,185.338,187.975,192.61,197.245,199.738,202.375,207.01,211.141,213.634,216.766,221.401,224.038,226.675,231.31,237.943,240.436,245.071,249.706,252.199,255.331,258.463,263.098,270.235,272.728,276.859,280.495,285.13,287.767,290.899,295.03" svgx:width="0.39,0.28,0.44,0.5,0.28,0.44,0.25,0.5,0.5,0.39,0.44,0.25,0.25,0.72,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.5,0.28,0.44,0.5,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.25,0.5,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.44,0.39,0.5,0.28,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">stable dose. One patient died during the follow up from aspira-</text>
   <text y="637.049" x="62.362,64.999,67.636,72.271,76.906,79.156,80.245,84.88,89.515,93.646,98.281,105.418,110.053,114.688,117.325,121.456,123.706,124.795,129.43,134.065,138.196,140.446,141.535,144.172,148.807,151.057,152.146,160.282,165.421,167.671,168.76,171.892,176.023,178.66,182.791,185.428,189.559,194.194,196.444,197.533,202.168,206.299,210.934,215.065,218.197,222.328,224.965,227.602,231.733,235.864,240.499,242.749,243.838,248.473,252.604,255.736,259.867,262.504,267.139,270.775,273.412,277.048,279.433,281.683,282.772,289.405,294.04,298.036" svgx:width="0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.44,0.5,0.78,0.5,0.5,0.28,0.44,0.25,0.55,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.28,0.44,0.44,0.5,0.25,0.55,0.5,0.44,0.33,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.72,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion pneumonia due to MS related generalized paralysis. One </text>
   <text y="648.047" x="62.362,66.997,71.128,73.765,76.402,80.533,85.168,87.805,90.055,91.216,95.851,100.486,103.123,107.254,111.889,114.139,115.3,117.937,122.572,124.822,125.983,129.115,133.246,140.383,145.018,149.653,153.784,156.034,157.195,159.832,164.467,168.598,170.848,172.009,176.644,181.279,188.416,193.051,195.436,197.686,198.847,203.482,207.613,211.744,215.875,220.51,224.146,228.277,230.527,231.688,236.323,238.96,242.596,244.846,246.007,249.643,254.278,258.409,262.045,264.682,267.319,271.45,274.087,276.724,281.359,283.609,284.77,289.405,293.536,298.036" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.44,0.78,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.78,0.5,0.25,0.25,0.55,0.5,0.44,0.44,0.44,0.5,0.39,0.44,0.25,0.55,0.5,0.28,0.39,0.25,0.55,0.39,0.5,0.44,0.39,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patient opted to remove the pump, because his spasticity had </text>
   <text y="659.045" x="62.362,64.999,72.136,76.771,79.903,84.538,89.173,93.304,97.939,100.171,104.806,109.441,113.572,116.704,118.936,121.573,124.21,131.347,135.478,137.71,140.347,144.982,147.214,149.851,154.486,158.617,160.849,165.484,170.119,172.756,177.391,180.028,182.26,184.897,189.532,193.663,196.3,198.532,203.167,207.298,209.53,214.165,216.802,221.437,223.669,228.304,232.939,235.576,237.808,240.94,245.071,249.706,254.341,256.978,260.11,264.241,266.473,269.11,273.745,276.382,279.514,283.645,286.282,290.917,295.048" svgx:width="0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.5,0.5,0.44,0.33,0.25,0.28,0.28,0.78,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.28,0.5,0.28,0.25,0.28,0.5,0.44,0.28,0.25,0.5,0.44,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.33,0.44,0.5,0.5,0.28,0.33,0.44,0.25,0.28,0.5,0.28,0.33,0.44,0.28,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">improved over time to the point that he did not require intrathe-</text>
   <text y="670.043" x="62.362,66.493,70.624,73.261,75.511,78.553,83.188,87.319,91.45,94.087,98.722,101.854,105.985,110.62,113.005,115.255,118.135,123.769,128.404,131.536,135.667,139.798,142.048,145.09,149.725,153.856,156.493,159.13,163.261,167.896,170.533,174.169,176.419,179.461,186.094,190.225,193.357,197.488,199.738,202.78,205.912,210.043,214.678,219.313,223.444,226.576,230.707,233.344,237.475,242.11,244.36,247.402,250.534,255.169,258.301,260.551,263.593,268.228,272.359,275.491,280.126,286.759,290.89,294.022,298.018" svgx:width="0.44,0.44,0.28,0.25,0.55,0.5,0.44,0.44,0.28,0.5,0.33,0.44,0.5,0.25,0.25,0.55,0.61,0.5,0.33,0.44,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.33,0.44,0.28,0.44,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.44,0.33,0.5,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cal baclofen. Three patients were reoperated for hardware </text>
   <text y="681.041" x="62.362,65.494,69.625,72.262,76.393,79.03,83.161,87.796,90.181,94.312,98.947,106.084,110.719,113.356,115.993,120.124,124.255,126.892,129.529,134.164,138.799,142.435" svgx:width="0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.78,0.5,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">related complications.</text>
   <text y="692.039" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="692.039" x="113.833,116.83,121.33,123.832,126.829,130.825,133.327,137.827,141.823,145.819,149.815,152.317,154.279,158.779,162.775,166.771,169.273,173.773,176.77,180.766,185.266,187.228,189.73,193.231,195.193,199.189,201.151,205.651,208.153,212.149,216.649,219.151,223.147,225.109,229.609,234.109,236.611,239.113,243.613,248.113,250.075,253.072,257.572,260.569,262.531,265.033,269.533,273.529,275.491,278.992,283.492,290.494,294.994" svgx:width="0.33,0.5,0.28,0.33,0.44,0.28,0.5,0.44,0.44,0.44,0.28,0.25,0.5,0.44,0.44,0.28,0.5,0.33,0.44,0.5,0.25,0.28,0.39,0.25,0.44,0.25,0.5,0.28,0.44,0.5,0.28,0.44,0.25,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.78,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Intrathecal baclofen is a viable option for the symp-</text>
   <text y="703.037" x="62.362,64.864,69.364,76.366,80.362,82.864,85.366,89.362,91.612,93.196,95.698,98.695,102.691,106.687,109.189,116.191,120.187,124.687,127.189,129.439,131.023,135.523,138.52,140.77,142.354,150.355,155.359,158.356,161.353,165.349,167.851,171.847,174.349,178.345,182.845,185.095,186.679,190.18,194.68,198.676,202.177,204.679,207.181,211.177,213.679,216.181,220.096,222.346,224.596,226.18,232.183,234.685,239.185,242.686,246.682,248.932,250.516,254.512,259.012,261.514,264.016,268.012,272.512,277.012,280.009,284.005,286.507,289.009,293.509,298.009" svgx:width="0.28,0.5,0.78,0.44,0.28,0.28,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.89,0.56,0.33,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.39,0.5,0.44,0.39,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.25,0.55,0.67,0.28,0.5,0.39,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.44,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tomatic treatment of MS-related spasticity. Close collaboration </text>
   <text y="714.035" x="62.362,68.86,71.362,73.864,78.364,80.614,82.369,86.365,88.615,90.37,94.87,98.866,103.366,106.363,110.863,114.364,118.864,121.699,126.199,128.701,132.697,136.693,139.195,141.445,143.2,147.196,151.192,155.692,158.194,162.19,165.187,167.437,169.192,171.694,176.194,180.19,182.692,184.942,186.697,193.195,197.695,202.195,204.697,209.197,211.447,213.202,217.702,221.698,226.198,230.698,233.2,237.196,239.446,241.201,245.197,249.697,254.197,256.447,258.202,261.703,266.203,269.038,273.538,276.04,280.036,284.032,286.534,288.784,290.539,295.039,298.036" svgx:width="0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.5,0.44,0.5,0.33,0.5,0.39,0.5,0.33,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.72,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.44,0.5,0.5,0.28,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.5,0.33,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with a neurosurgical center that would handle any surgical or </text>
   <text y="725.033" x="62.362,66.862,70.858,73.855,78.355,84.853,88.849,91.846,95.842,98.092,101.089,105.085,107.587,111.583,114.085,118.081,122.581,124.831,128.827,133.327,140.329,144.829,147.331,149.833,153.829,157.825,160.327,162.829,167.329,171.829,175.33,177.58,180.082,183.583,185.833,190.333,193.33,195.58,199.576,203.077,206.578,210.574,215.074,219.07,223.066" svgx:width="0.5,0.44,0.33,0.5,0.72,0.44,0.33,0.44,0.25,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.78,0.5,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.28,0.39,0.25,0.5,0.33,0.25,0.44,0.39,0.39,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">hardware related complications is of essence.</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 122.160 L342.760 122.160 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 726.160 L344.750 726.160 "/>
  <g begin="text">
   <text y="76.959" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P924</text>
   <text y="87.957" x="310.016,315.02,319.52,322.517,326.513,329.51,334.01,336.26,338.51,343.514,348.518,353.018,355.52,358.022,361.019,365.519,367.769,372.269,375.266,377.516,380.018,382.52,385.517,389.513,391.763,394.013,398.513,403.517,408.521,410.771,417.269,421.769,424.271,429.275,431.777,436.781,441.281,443.531,448.031,453.035,455.537,458.039,460.541,463.538,468.038,470.288,476.786,479.288,482.285,487.289,489.539,495.038,501.536" svgx:width="0.56,0.5,0.33,0.44,0.33,0.5,0.25,0.25,0.56,0.56,0.5,0.28,0.28,0.33,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.25,0.5,0.56,0.56,0.25,0.72,0.5,0.28,0.56,0.28,0.56,0.5,0.25,0.5,0.56,0.28,0.28,0.28,0.33,0.5,0.25,0.72,0.28,0.33,0.56,0.25,0.61,0.72,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Safety, quality of life, and walking ability with PR-</text>
   <text y="98.955" x="310.016,313.013,317.513,325.01,330.014,334.01,336.512,341.516,344.018,349.022,353.018,355.268,358.265,362.261,366.257,370.757,373.754,381.251,385.247,390.251,393.248,395.498,398.0,403.004,405.254,409.25,411.752,414.254,419.258,421.76,425.756,430.256,432.758,435.008,440.012,444.008,448.508,452.504,455.501,458.003,461.999,465.995,468.245,470.747,475.751,478.001,483.5,487.496,491.996,497.0,500.996,504.992,507.989" svgx:width="0.33,0.5,0.83,0.56,0.44,0.28,0.56,0.28,0.56,0.44,0.25,0.33,0.44,0.44,0.5,0.33,0.83,0.44,0.56,0.33,0.25,0.28,0.56,0.25,0.44,0.28,0.28,0.56,0.28,0.44,0.5,0.28,0.25,0.56,0.44,0.5,0.44,0.33,0.28,0.44,0.44,0.25,0.28,0.56,0.25,0.61,0.44,0.5,0.56,0.44,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">fampridine treatment in clinical practice in France: </text>
   <text y="109.953" x="310.016,312.518,317.522,320.519,324.515,328.511,331.013,338.51,340.76,344.756,348.752,352.253,357.257,359.759,362.756,366.257,368.507,373.007,376.004,378.254,381.251,386.255,390.251,392.501,398.504,402.005,408.008,414.011,420.509,427.007,433.01,439.013,441.263,444.764,447.761,452.765,457.769" svgx:width="0.28,0.56,0.33,0.44,0.44,0.28,0.83,0.25,0.44,0.44,0.39,0.56,0.28,0.33,0.39,0.25,0.5,0.33,0.25,0.33,0.56,0.44,0.25,0.67,0.39,0.67,0.67,0.72,0.72,0.67,0.67,0.25,0.39,0.33,0.56,0.56,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">interim results of the LIBERATE study</text>
   <text y="120.951" x="310.016,313.517,316.514,321.518,323.768,330.266,334.262,338.258" svgx:width="0.39,0.33,0.56,0.25,0.72,0.44,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">J-P Neau</text>
   <text y="118.439" x="342.757" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="120.959" x="345.682,347.932,350.182,356.68,358.93,364.933,368.929,372.43,374.932,378.928,381.43,385.93,390.43,394.93" svgx:width="0.25,0.25,0.72,0.25,0.67,0.44,0.39,0.28,0.44,0.28,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Castelnovo</text>
   <text y="118.439" x="399.43" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="120.959" x="402.355,404.605,406.855,412.354,414.604,419.608,424.108,426.61,430.111,433.612,438.112" svgx:width="0.25,0.25,0.61,0.25,0.56,0.5,0.28,0.39,0.39,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Soisson</text>
   <text y="118.439" x="442.612" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="120.959" x="445.536,447.786,450.036,456.534,458.784,465.282,471.78,474.282,478.278,480.78,485.28,489.78,496.278,499.779,504.279" svgx:width="0.25,0.25,0.72,0.25,0.72,0.72,0.28,0.44,0.28,0.5,0.5,0.72,0.39,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Kwiatkowski</text>
   <text y="118.439" x="506.781" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="120.959" x="509.706,511.956,514.206,522.207" svgx:width="0.25,0.25,0.89,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M </text>
   <text y="131.957" x="310.014,318.015,322.011,328.509,332.505,335.007,337.509" svgx:width="0.89,0.44,0.72,0.44,0.28,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">McNeill</text>
   <text y="129.439" x="340.012" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">5</text>
   <text y="131.959" x="342.937,345.187,347.437,355.438,357.688,364.186,368.182" svgx:width="0.25,0.25,0.89,0.25,0.72,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Yeh</text>
   <text y="129.439" x="372.682" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">6</text>
   <text y="140.437" x="310.017" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="142.959" x="312.941,318.944,325.442,331.94,334.19,339.689,344.189,346.691,349.193,351.695,355.691,359.192,362.693,364.943,367.94,370.19,376.688,381.188,385.688,388.19,390.692,395.192,397.694,399.944,402.446,406.946,409.196,416.693,419.195,421.697,425.693,428.195,431.696,434.198,438.194,440.444,442.694,448.193,452.693,455.195,457.697,460.199,464.195,467.696,471.197,473.447,475.697,481.196,484.697,489.197,493.697,497.693,501.689,503.939" svgx:width="0.67,0.72,0.72,0.25,0.61,0.5,0.28,0.28,0.28,0.44,0.39,0.39,0.25,0.33,0.25,0.72,0.5,0.5,0.28,0.28,0.5,0.28,0.25,0.28,0.5,0.25,0.83,0.28,0.28,0.44,0.28,0.39,0.28,0.44,0.25,0.25,0.61,0.5,0.28,0.28,0.28,0.44,0.39,0.39,0.25,0.25,0.61,0.39,0.5,0.5,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">CHU Poitiers - Hôpital la Milétrie, Poitiers, France, </text>
   <text y="140.439" x="506.187" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="142.959" x="509.112,515.115,521.613,528.111" svgx:width="0.67,0.72,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">CHU </text>
   <text y="153.957" x="310.014,314.514,318.51,320.76,326.763,329.265,335.763,339.759,343.26,345.51,348.507,350.757,357.255,361.755,366.255,368.757,371.259,375.759,378.261,380.511,386.514,391.014,394.515,398.511,405.009,409.005,413.505,418.005,420.255,422.505,428.508,431.01,437.508,441.504,445.005,447.255,449.505,455.004,458.505,463.005,467.505,471.501,475.497,477.747" svgx:width="0.5,0.44,0.25,0.67,0.28,0.72,0.44,0.39,0.25,0.33,0.25,0.72,0.5,0.5,0.28,0.28,0.5,0.28,0.25,0.67,0.5,0.39,0.44,0.72,0.44,0.5,0.5,0.25,0.25,0.67,0.28,0.72,0.44,0.39,0.25,0.25,0.61,0.39,0.5,0.5,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">de Nimes - Hopital Carémeau, Nimes, France, </text>
   <text y="151.439" x="479.997" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="153.959" x="482.922,488.925,493.425,497.925,500.427,504.927,508.923,511.425,513.675,518.175,522.171" svgx:width="0.67,0.5,0.5,0.28,0.5,0.44,0.28,0.25,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Cabinet de </text>
   <text y="164.957" x="310.014,316.017,320.013,324.513,328.014,332.514,335.016,339.516,344.016,346.518,350.514,352.764,355.014,361.512,365.013,367.515,371.511,376.011,380.511,384.012,386.262,388.512,394.011,397.512,402.012,406.512,410.508,414.504,416.754" svgx:width="0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.28,0.44,0.25,0.25,0.72,0.39,0.28,0.44,0.5,0.5,0.39,0.25,0.25,0.61,0.39,0.5,0.5,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Neurologie, Orléans, France, </text>
   <text y="162.439" x="419.004" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="164.959" x="421.93,428.427,434.925,437.922,443.925,448.929,451.926,454.176,460.674,465.174,469.674,472.176,474.678,479.178,481.681,483.931,488.431,492.931,495.433,499.933,502.435,504.685,510.184,512.686,517.186,521.182,525.177,529.677,532.18,534.43,538.93,542.925" svgx:width="0.72,0.72,0.33,0.67,0.56,0.33,0.25,0.72,0.5,0.5,0.28,0.28,0.5,0.28,0.25,0.5,0.5,0.28,0.5,0.28,0.25,0.61,0.28,0.5,0.44,0.44,0.5,0.28,0.25,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">GHICL- Hopital Saint Vincent de </text>
   <text y="175.957" x="310.014,315.513,320.013,324.513,327.016,329.266,331.516,336.52,339.022,341.524,344.026,348.022,350.272,352.522,358.021,361.522,366.022,370.522,374.518,378.514,380.764" svgx:width="0.61,0.5,0.5,0.28,0.25,0.25,0.56,0.28,0.28,0.28,0.44,0.25,0.25,0.61,0.39,0.5,0.5,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Paul, Lille, France, </text>
   <text y="173.439" x="383.014" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">5</text>
   <text y="175.959" x="385.939,391.438,393.94,398.44,402.94,406.936,411.436,413.686,416.683,421.183,425.179,429.175,431.425,433.675,441.172,445.672,448.174,452.674,456.67,461.17,465.67,469.666,474.166,478.666,480.916,483.166,489.664,494.164,496.666,499.168,503.164,507.664,509.914,515.917,518.419,522.919,527.419,531.919,536.419,542.917,545.167" svgx:width="0.61,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.44,0.44,0.25,0.25,0.83,0.5,0.28,0.5,0.44,0.5,0.5,0.44,0.5,0.5,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Biogen Idec, Maidenhead, United Kingdom, </text>
   <text y="184.439" x="310.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">6</text>
   <text y="186.959" x="312.941,318.44,320.942,325.442,329.942,333.938,338.438,340.688,343.685,348.185,352.181,356.177,358.427,360.677,366.68,371.18,377.678,382.178,385.679,388.181,392.681,397.181,401.177,403.427,405.677,413.174,418.673,420.923,423.173,429.671,434.171,436.673,439.175,443.171,447.671,449.921,454.421,456.923,461.423,463.925,467.921" svgx:width="0.61,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.44,0.44,0.25,0.25,0.67,0.5,0.72,0.5,0.39,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Biogen Idec, Cambridge, MA, United States</text>
   <text y="213.959" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="213.959" x="362.198,365.195,372.197,376.697,380.693,383.195,386.192,390.188,394.688,396.524,403.022,407.018,409.52,414.02,416.522,421.022,425.522,427.358,431.858,435.854,440.354,444.35,446.852,449.354,453.854,457.85,460.352,464.852,466.688,469.19,476.192,480.692,484.688,488.684,491.186,494.687,496.523,501.023,505.019,507.521,510.023,514.019,518.519,521.021,524.522,526.853,528.689,531.191,533.693,538.193,542.189,545.69" svgx:width="0.33,0.78,0.5,0.44,0.28,0.33,0.44,0.5,0.25,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.39,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.33,0.25,0.28,0.28,0.5,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Impaired walking negatively impacts patients’ lives </text>
   <text y="224.957" x="310.016,314.012,318.512,323.012,325.262,326.126,328.628,332.129,334.379,335.243,339.239,342.74,346.241,350.741,354.737,357.239,361.235,363.737,367.733,372.233,374.483,375.347,381.845,384.347,386.849,391.349,393.599,394.463,397.46,401.456,405.956,410.456,414.452,418.448,422.948,425.198,426.062,430.562,435.062,439.058,441.56,444.062,446.564,451.064,453.314,454.178,458.678,461.675,463.925,464.789,467.291,469.793,472.79,476.786,479.036,479.9,482.897,489.395,493.895,499.394,502.391,504.641,505.505,508.007,512.507,514.757,515.621,522.623,527.123,529.625,532.127,534.629,539.129,541.631,545.627" svgx:width="0.44,0.5,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.55,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.28,0.33,0.44,0.25,0.55,0.33,0.72,0.5,0.61,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and is associated with reduced quality of life (QoL) in multiple </text>
   <text y="235.955" x="310.016,313.517,317.513,320.015,324.011,327.008,331.508,335.009,337.511,341.012,342.839,345.836,353.837,358.841,361.838,364.088,365.915,370.919,373.916,378.416,380.918,385.418,389.918,394.418,398.414,402.914,405.911,408.908,412.904,415.406,419.402,423.398,426.899,430.895,432.722,435.719,440.723,446.726,449.723,451.55,454.547,458.543,465.545,470.045,473.042,475.544,480.044,482.546,487.046,491.042,492.869,495.371,499.367,503.867,506.369,510.365,512.867,514.694,517.691,522.191,526.187,528.689,531.686,535.682,542.684" svgx:width="0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.25,0.56,0.33,0.5,0.28,0.5,0.5,0.5,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.33,0.56,0.67,0.33,0.25,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.28,0.44,0.5,0.28,0.44,0.28,0.25,0.33,0.5,0.44,0.28,0.33,0.44,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sclerosis (MS). Prolonged-release (PR) fampridine tablet (dalfam-</text>
   <text y="246.953" x="310.016,314.516,317.513,320.015,324.515,327.017,331.517,335.513,337.763,339.131,343.127,347.627,350.129,354.125,358.625,363.125,367.121,371.621,373.871,375.239,378.236,382.232,384.734,388.73,392.726,396.227,400.223,402.473,403.841,406.343,410.843,413.093,414.461,416.963,421.463,425.459,427.709,429.077,435.575,440.075,442.577,445.079,449.075,453.575,455.825,457.193,462.197,464.699,468.695,471.197,475.193,478.694,481.691,483.941,485.309,487.811,491.312,493.562,494.93,497.432,501.932,505.928,508.178,509.546,514.046,518.546,521.048,525.548,527.798,529.166,533.666,536.663,541.163,545.663" svgx:width="0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.44,0.5,0.5,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.56,0.28,0.44,0.28,0.44,0.39,0.33,0.25,0.55,0.28,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pridine extended release in the United States) is the only drug </text>
   <text y="257.951" x="310.016,312.518,317.018,321.518,324.02,328.016,332.012,334.514,338.51,343.01,345.26,347.762,352.262,354.512,357.014,364.016,368.516,371.513,376.013,380.513,384.509,386.759,393.257,397.253,399.755,404.255,406.757,411.257,415.757,418.007,420.509,425.009,427.259,435.26,440.264" svgx:width="0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.25,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">indicated to improve walking in MS.</text>
   <text y="268.949" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="268.949" x="355.745,360.614,365.114,367.355,371.351,375.851,378.353,380.855,384.851,388.847,391.349,393.59,396.092,400.592,405.092,409.592,412.589,415.091,419.087,422.084,429.086,431.336,433.577,436.574,440.57,444.566,447.068,450.065,452.567,455.069,458.066,462.062,464.303,468.803,472.799,475.301,479.297,481.538,486.038,490.538,492.779,496.28,500.276,503.273,507.269,509.771,513.686,515.936,518.177,522.677,526.673,529.175,531.677,535.673,540.173,542.675" svgx:width="0.61,0.5,0.25,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.25,0.28,0.5,0.5,0.5,0.33,0.28,0.44,0.33,0.78,0.25,0.25,0.33,0.44,0.44,0.28,0.33,0.28,0.28,0.33,0.44,0.25,0.5,0.44,0.28,0.44,0.25,0.5,0.5,0.25,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To collect long-term, real-life data on safety, patient-</text>
   <text y="279.947" x="310.016,313.013,317.009,321.509,326.009,329.006,331.508,335.504,340.004,342.254,344.918,351.416,355.916,361.415,363.665,365.915,368.588,372.584,377.084,381.584,383.834,386.498,390.998,395.498,399.998,403.499,406.001,409.997,412.499,416.495,420.995,423.992,426.989,430.985,435.485,439.985,442.982,445.484,449.48,453.98,456.23,458.894,465.392,469.388,471.89,476.39,478.892,483.392,487.892,490.142,492.806,496.802,501.302,503.804,506.306,508.808,511.31,515.81,518.06,520.733,523.235,527.735,529.985,532.658,540.659,545.663" svgx:width="0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.72,0.5,0.61,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.39,0.28,0.44,0.28,0.44,0.5,0.33,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">reported QoL, and physician-reported walking ability in MS </text>
   <text y="290.945" x="310.016,314.516,318.512,321.014,323.516,327.512,332.012,334.514,338.015,340.265,342.767,345.764,349.76,353.756,356.258,360.254,364.754,367.004,373.502,376.004,378.506,383.006,385.256,390.26,396.263,399.26,402.257,406.253,413.255,417.755,420.752,423.254,427.754,430.256,434.756,438.752" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.56,0.67,0.33,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients treated with PR-fampridine.</text>
   <text y="301.943" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="301.943" x="349.04,354.539,357.536,363.539,369.038,375.041,380.54,386.039,391.538,394.067,396.569,400.07,402.599,406.595,409.124,413.624,416.621,421.121,424.622,429.122,433.118,437.114,439.616,442.118,446.618,450.614,452.864,455.393,459.893,464.393,468.893,471.395,475.895,478.397,482.393,485.39,489.89,493.886,498.386,500.888,503.39,507.89,512.39,516.386,518.888,521.138,523.667,530.669,535.169,537.671,540.173,542.675" svgx:width="0.61,0.33,0.67,0.61,0.67,0.72,0.61,0.61,0.25,0.28,0.39,0.25,0.44,0.25,0.5,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.5,0.5,0.5,0.28,0.5,0.28,0.44,0.33,0.5,0.44,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.25,0.78,0.5,0.28,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">LIBERATE is a prospective, noninterventional, multi-</text>
   <text y="312.941" x="310.016,314.012,318.008,322.508,325.01,329.006,331.643,333.893,336.143,337.151,341.651,346.151,349.652,353.648,356.645,361.145,365.141,367.643,370.145,374.645,379.145,383.141,385.643,387.893,388.901,392.402,394.904,399.404,403.904,408.404,410.654,411.662,414.164,418.664,420.914,421.922,426.422,430.418,432.92,435.422,439.418,443.918,446.42,449.921,452.171,453.179,457.679,461.675,466.175,468.677,473.177,477.677,480.179,484.679,489.179,491.429,492.437,494.939,497.936,501.932,505.928,508.43,515.432,519.428,523.928,526.43,528.68,529.688,536.186,538.688,541.19,545.69" svgx:width="0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">center, observational study in patients beginning treatment with </text>
   <text y="323.939" x="310.016,315.02,321.023,324.02,327.017,331.013,338.015,342.515,345.512,348.014,352.514,355.016,359.516,363.512,366.329,370.829,375.329,378.146,385.148,389.648,392.465,394.967,398.963,403.463,405.965,409.961,412.463,415.28,417.782,424.28,426.782,430.778,434.774,437.591,442.091,446.087,448.589,451.091,455.591,458.408,460.91,465.41,468.227,472.223,475.04,478.037,482.537,487.037,489.539,492.041,496.541,500.537,503.354,507.35,509.852,512.354,516.854,519.356,523.352,527.348,529.85,532.667,536.168,540.164,542.666" svgx:width="0.56,0.67,0.33,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.5,0.5,0.25,0.78,0.5,0.25,0.28,0.44,0.5,0.28,0.44,0.28,0.25,0.28,0.72,0.28,0.44,0.44,0.25,0.5,0.44,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.44,0.25,0.33,0.5,0.5,0.28,0.28,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.39,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PR-fampridine 10 mg tablet twice daily in a routine clinical set-</text>
   <text y="334.937" x="310.016,312.518,315.02,319.52,324.02,326.27,328.187,333.191,335.693,340.193,344.693,349.193,351.11,355.106,359.606,362.603,367.103,369.605,372.107,379.109,383.105,387.605,390.107,392.024,396.524,400.52,405.02,409.016,413.516,414.938,421.436,425.936,428.933,431.435,433.937,435.854,440.354,444.854,447.104,449.021,453.521,458.021,462.521,467.021,468.938,475.436,477.938,480.44,484.94,486.857,491.357,495.857,500.357,502.274,506.27,510.77,513.767,516.764,520.76,525.26,527.762,529.679,533.18,535.682,538.184,542.18,545.681" svgx:width="0.28,0.28,0.5,0.5,0.25,0.25,0.56,0.28,0.5,0.5,0.5,0.25,0.44,0.5,0.33,0.5,0.28,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.5,0.44,0.5,0.25,0.72,0.5,0.33,0.28,0.28,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.5,0.5,0.25,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.39,0.28,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ting. Study enrollment began April 16, 2012 with 128 current sites </text>
   <text y="345.935" x="310.016,314.516,317.513,320.015,327.017,331.013,334.01,336.512,339.014,343.514,345.764,347.672,350.174,354.674,356.924,358.841,365.339,369.335,372.332,379.334,383.33,387.83,392.33,394.58,396.488,400.484,404.984,409.484,411.734,413.651,418.655,421.652,425.648,430.148,434.144,438.14,440.39,442.64,444.548,451.046,455.042,457.544,461.54,463.79,465.698,472.196,476.192,479.189,483.185,485.435,487.343,491.339,495.839,498.341,500.843,504.839,508.835,511.337,515.333,519.833,522.083,523.991,527.987,530.489,532.739,534.656,537.158,541.658,545.654" svgx:width="0.5,0.33,0.28,0.78,0.44,0.33,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.44,0.33,0.78,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.56,0.33,0.44,0.5,0.44,0.44,0.25,0.25,0.55,0.72,0.44,0.28,0.44,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">primarily in Germany and France. Data were collected at the </text>
   <text y="356.933" x="310.016,314.012,318.512,321.509,326.009,328.511,331.013,338.015,342.011,346.511,349.013,351.749,356.249,358.751,362.252,364.754,367.256,369.992,372.989,377.489,381.485,384.986,388.982,391.484,393.986,398.486,402.482,405.479,408.215,412.211,416.711,421.211,423.947,428.447,432.947,435.944,438.446,442.946,447.446,450.182,453.179,457.679,460.181,462.683,467.183,473.681,476.678,481.178,485.678,488.414,492.914,495.416,498.917,501.419,503.921,507.422,510.158,514.154,518.15,522.146,526.646,529.643,534.143,536.645,541.145,545.645" svgx:width="0.44,0.5,0.33,0.5,0.28,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.28,0.39,0.28,0.28,0.25,0.33,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.5,0.28,0.39,0.28,0.28,0.39,0.25,0.44,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">enrollment visit (baseline) and during follow-up visits according </text>
   <text y="367.931" x="310.016,312.518,317.018,319.097,321.599,326.099,330.095,334.091,336.593,338.672,341.669,346.169,350.669,353.171,355.673,360.173,364.169,366.248,370.244,372.746,375.248,379.748,382.25,386.246,390.242,392.744,394.823,399.323,402.32,406.316,410.312,412.814,415.316,419.312,423.308,426.809,429.311,431.39,435.89,439.886,442.388,446.384,448.463,452.459,456.959,459.461,461.963,465.959,469.955,472.457,476.453,480.953,483.032,487.532,491.528,494.03,500.528,504.524,508.52,513.02,515.099,521.597,525.593,530.093,532.172,536.672,541.172,545.672" svgx:width="0.28,0.5,0.25,0.28,0.5,0.44,0.44,0.28,0.25,0.33,0.5,0.5,0.28,0.28,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.33,0.44,0.44,0.28,0.28,0.44,0.44,0.39,0.28,0.25,0.5,0.44,0.28,0.44,0.25,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.72,0.44,0.5,0.25,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to local routine clinical practices; data collected between Day 136 </text>
   <text y="378.929" x="310.016,314.012,318.512,323.012,325.406,329.906,334.406,338.906,341.3,345.296,348.293,352.289,354.683,357.68,361.676,366.176,370.676,373.673,376.175,380.171,384.671,387.065,391.061,394.562,396.956,404.957,409.457,413.957,416.459,420.959,423.353,427.853,430.247,433.244,437.744,440.246,442.748,447.248,453.746,456.743,461.243,465.743,467.993,470.387,475.391,479.387,481.889,484.391,488.387,492.887,495.389,498.89,501.284,507.782,512.282,516.782,519.176,523.676,526.178,529.679,533.675,538.175,542.675" svgx:width="0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.44,0.33,0.44,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.44,0.39,0.25,0.89,0.5,0.5,0.28,0.5,0.25,0.5,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.25,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and 270 are reported as Month 6 follow-up. Patients who discon-</text>
   <text y="389.927" x="310.016,312.518,315.02,319.52,324.02,328.016,332.516,334.505,337.007,340.004,344.0,347.996,350.498,357.5,361.496,365.996,368.498,370.487,376.985,380.981,383.978,387.974,389.963,393.959,398.459,402.455,406.955,411.455,414.452,418.448,422.948,426.944,431.444,433.433,435.935,440.435,442.424,445.925,448.427,452.423,456.923,458.912,461.414,465.914,467.903,470.405,474.905,478.901,480.89,484.391,486.893,491.393,495.893,500.393,502.382,505.379,509.879,513.875,516.377,518.879,522.875,527.375,529.877,533.378,535.367,539.867,542.702,545.699" svgx:width="0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.5,0.5,0.33,0.44,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.39,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.33,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tinued treatment were encouraged to stay in the study (patients off </text>
   <text y="400.925" x="310.016,312.518,315.515,319.511,323.507,326.009,333.011,337.007,341.507,344.009,347.006,349.256,351.074,356.573,361.073,365.573,370.073,374.573,377.075,381.575,384.077,387.578,389.396,391.898,396.398,400.394,402.896,407.396,411.896,415.892,420.392,422.21,424.712,429.212,433.208,435.71,440.21,444.206,448.706,452.702,456.698,458.516,463.016,466.013,467.831,471.827,476.327,480.827,484.823,487.82,491.321,495.317,497.135,501.131,505.631,509.627,514.127,516.629,520.13,521.948,524.945,531.443,536.942,540.443,543.44,545.69" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.33,0.25,0.25,0.61,0.5,0.5,0.5,0.5,0.28,0.5,0.28,0.39,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.44,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.33,0.72,0.61,0.39,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment). Endpoints included incidence of adverse events (AEs), </text>
   <text y="411.923" x="310.016,314.516,319.016,323.516,327.017,329.519,333.515,336.017,340.013,344.513,347.51,351.506,355.007,358.508,362.504,366.005,369.506,373.502,378.002,380.252,381.737,387.74,390.242,392.744,397.244,399.746,403.742,407.738,410.24,412.49,413.975,420.473,422.975,427.475,431.975,435.971,438.473,440.723,442.208,445.205,452.207,456.707,459.704,463.7,467.201,470.702,473.204,477.704,482.204,484.454,485.939,490.439,493.436,495.686,497.171,500.168,507.17,511.67,514.667,519.167,523.667,527.663,534.665,538.661,543.161,545.663" svgx:width="0.5,0.5,0.5,0.39,0.28,0.44,0.28,0.44,0.5,0.33,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.55,0.67,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.72,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.33,0.78,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">physician-assessed Clinical Global Impression of Improvement </text>
   <text y="422.921" x="310.016,313.013,319.016,325.514,328.511,331.508,334.505,337.502,340.355,344.855,347.852,350.705,357.203,361.199,363.701,368.201,370.703,375.203,379.703,382.556,386.552,391.052,393.554,396.056,398.558,401.06,405.56,408.413,412.409,416.909,421.409,424.262,428.762,432.758,435.26,437.762,441.758,446.258,448.76,451.262,454.763,457.616,461.612,465.113,468.614,472.61,476.111,479.612,486.614,490.61,495.11,497.612,500.465,504.965,507.962,510.815,513.317,520.319,524.819,528.815,532.811,535.313,538.166,542.666,545.663" svgx:width="0.33,0.67,0.72,0.33,0.33,0.33,0.33,0.25,0.5,0.33,0.25,0.72,0.44,0.28,0.5,0.28,0.5,0.5,0.25,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.33,0.39,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(CGI-I) of walking ability and patient’s assessment of impact of </text>
   <text y="433.919" x="310.016,318.017,323.021,325.271,326.162,330.662,334.163,336.665,341.165,345.665,347.915,348.806,351.308,355.808,359.804,362.054,362.945,370.946,375.446,377.948,380.45,382.952,387.452,389.954,393.95,396.2,397.091,402.095,406.091,408.593,412.589,415.586,420.086,423.587,426.089,429.59,431.84,432.731,435.728,442.73,447.23,451.226,455.222,457.724,459.974,460.865,465.869,469.865,473.861,476.363,480.359,483.356,487.856,492.356,494.606,495.497,498.494,500.996,504.992,511.994,515.495,517.745,518.636,521.633,529.634,534.638,537.635,542.639" svgx:width="0.89,0.56,0.25,0.55,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.89,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.56,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.78,0.5,0.44,0.44,0.28,0.25,0.55,0.56,0.44,0.44,0.28,0.44,0.33,0.5,0.5,0.25,0.55,0.33,0.28,0.44,0.78,0.39,0.25,0.55,0.33,0.89,0.56,0.33,0.56,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MS using the Multiple Sclerosis Impact Scale-29 Items (MSIS-</text>
   <text y="444.917" x="310.016,314.516,319.016,322.013,324.263,326.378,332.381,336.377,340.877,345.377,348.374,350.876,354.872,359.372,361.487,365.987,369.983,372.98,376.976,379.091,383.087,386.084,390.08,392.195,394.697,399.197,401.699,405.695,408.692,411.194,418.196,420.311,423.308,427.304,430.805,435.305,437.807,440.309,443.81,445.925,448.922,451.919,456.419,463.421,465.536,468.038,472.538,476.534,478.649,483.653,486.65,490.646,495.146,499.142,503.642,505.757,509.258,511.76,516.26,520.76,525.26,527.375,530.876,533.378,535.88,539.876,543.377" svgx:width="0.5,0.5,0.33,0.25,0.25,0.67,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.5,0.44,0.33,0.44,0.25,0.44,0.33,0.44,0.25,0.28,0.5,0.28,0.44,0.33,0.28,0.78,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.25,0.56,0.33,0.44,0.5,0.44,0.5,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.39,0.28,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">29). Reported here are interim results from the French study sites.</text>
   <text y="455.915" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="455.915" x="344.855,351.353,354.35,356.6,358.193,360.695,365.195,369.191,371.441,373.034,377.534,382.034,386.534,388.784,390.377,394.877,398.873,401.375,403.877,407.873,412.373,414.875,418.376,420.626,422.219,426.215,430.715,433.712,438.212,440.714,443.216,447.212,451.712,453.962,455.555,458.057,462.557,464.807,466.4,468.902,473.402,477.398,479.648,481.241,486.245,489.242,493.238,497.738,501.734,506.234,508.484,510.077,513.578,516.08,518.582,522.578,526.079,528.329,530.579,532.172,536.672,541.172,545.672" svgx:width="0.72,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.56,0.33,0.44,0.5,0.44,0.5,0.25,0.55,0.39,0.28,0.28,0.44,0.39,0.25,0.25,0.55,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Of the 989 patients enrolled in the French sites, 765 </text>
   <text y="466.913" x="310.016,314.516,318.512,321.014,323.516,327.512,332.012,334.514,338.015,340.265,344.954,351.452,353.954,356.456,360.956,363.206,367.895,371.891,374.141,378.83,385.832,389.828,394.328,396.83,400.826,405.326,407.576,412.265,417.764,424.262,429.266,434.27,436.52,441.209,445.709,448.706,450.956,455.645,460.145,462.395,466.895,469.145,473.834,480.332,484.328,487.325,491.321,493.571,498.26,500.762,503.759,507.755,511.751,514.253,518.249,522.749,524.999,529.688,536.186,538.688,541.19,545.69" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.78,0.44,0.5,0.28,0.44,0.5,0.25,0.55,0.61,0.72,0.56,0.56,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.25,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients with a median EDSS of 5.5 were treated with </text>
   <text y="477.911" x="310.016,315.02,321.023,324.02,327.017,331.013,338.015,342.515,345.512,348.014,352.514,355.016,359.516,363.512,365.762,367.175,373.673,377.174,379.082,383.582,386.579,388.487,391.988,395.984,400.484,404.984,408.98,411.977,416.477,418.385,422.885,427.385,431.885,436.385,438.635,440.543,445.043,449.543,454.043,455.951,458.453,461.45,465.446,469.442,471.944,475.94,480.44,482.348,486.848,490.844,493.346,495.848,499.844,504.344,506.846,510.347,512.255,516.755,520.751,525.251,527.159,531.155,535.655,542.657" svgx:width="0.56,0.67,0.33,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.25,0.72,0.39,0.25,0.5,0.33,0.25,0.39,0.44,0.5,0.5,0.44,0.33,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.44,0.5,0.25,0.44,0.5,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PR-fampridine. As of January 2014, 403 treated patients had com-</text>
   <text y="488.909" x="310.016,314.516,317.018,321.014,323.516,327.512,332.012,334.262,336.989,339.491,343.991,347.987,350.237,352.964,357.464,360.461,367.463,371.963,376.463,378.965,383.465,385.715,388.442,391.439,395.939,398.441,400.943,405.443,411.941,414.938,419.438,423.938,426.188,428.915,431.912,436.412,440.408,442.91,445.412,449.408,453.908,456.41,459.911,462.161,464.888,469.388,473.888,476.138,478.865,481.367,484.364,488.36,492.356,494.858,501.86,505.856,510.356,512.858,515.108,517.358,520.085,524.585,529.661,534.161,538.661,543.161,545.663" svgx:width="0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.78,0.5,0.5,0.28,0.5,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.55,0.33,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.55,0.5,0.56,0.5,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pleted the 6-month follow-up (patients on treatment, n=274; </text>
   <text y="499.907" x="310.016,314.516,318.512,321.014,323.516,327.512,332.012,334.514,338.015,339.896,344.396,347.231,350.228,352.109,354.611,357.608,361.604,365.6,368.102,375.104,379.1,383.6,386.102,388.352,390.233,394.733,399.809,404.309,408.809,413.309,416.306,418.556,420.437,426.935,429.932,431.813,435.809,438.311,440.813,442.694,445.196,448.193,452.189,456.185,458.687,462.683,467.183,469.064,473.564,477.56,480.062,482.564,486.56,491.06,493.562,497.063,498.944,501.941,506.441,511.517,516.017,520.517,525.017,528.014,530.264,532.145,536.645,541.145,545.645" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.33,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.5,0.56,0.5,0.5,0.5,0.33,0.25,0.25,0.72,0.33,0.25,0.44,0.28,0.28,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.56,0.5,0.5,0.5,0.33,0.25,0.25,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients off treatment, n=129). Of all treated patients (n=765), 265 </text>
   <text y="510.905" x="310.016,313.013,317.513,322.013,329.51,332.507,335.099,339.599,342.101,345.602,349.598,354.098,358.598,361.1,363.602,368.102,372.602,376.598,381.098,383.69,386.192,389.189,393.185,397.181,399.683,406.685,410.681,415.181,417.683,420.185,422.777,427.277,431.777,436.277,438.878,441.875,446.375,450.875,458.372,461.369,463.961,468.461,472.961,476.957,479.558,482.06,486.56,489.152,491.654,495.65,499.646,504.146,506.738,511.238,514.235,516.836,520.832,523.667,526.664,529.166,533.162,537.158,541.154,545.654" svgx:width="0.33,0.5,0.5,0.83,0.33,0.25,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.28,0.25,0.5,0.5,0.5,0.25,0.33,0.5,0.5,0.83,0.33,0.25,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.28,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(35%) discontinued treatment: 167 (22%) due to lack of efficacy </text>
   <text y="521.903" x="310.016,314.012,318.512,323.012,325.262,326.504,331.004,335.504,337.754,338.996,341.993,346.493,350.993,358.49,361.487,363.737,364.979,369.479,373.979,377.975,380.225,381.467,383.969,388.469,390.719,391.466,397.964,403.463,406.964,409.214,411.464,412.706,417.71,421.706,424.208,426.71,430.706,435.206,437.708,441.209,443.459,444.701,447.203,450.2,454.196,458.192,460.694,464.69,469.19,471.44,472.682,479.18,481.682,484.184,488.684,490.934,492.176,497.18,503.183,506.18,509.177,513.173,520.175,524.675,527.672,530.174,534.674,537.176,541.676,545.672" svgx:width="0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.83,0.33,0.25,0.55,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.61,0.39,0.25,0.25,0.55,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.56,0.67,0.33,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and 88 (12%) due to AEs. Patients treated with PR-fampridine </text>
   <text y="532.901" x="310.016,314.516,318.512,325.514,330.014,334.514,338.015,340.517,343.514,347.51,350.012,354.008,358.508,360.389,362.891,369.893,374.393,377.39,381.89,386.39,390.386,397.388,401.384,405.884,408.386,410.267,413.264,420.266,424.262,428.258,432.758,434.639,438.635,443.135,447.131,451.631,456.131,460.127,462.008,465.005,468.002,472.502,479.504,481.385,485.885,489.881,493.382,497.378,499.88,502.382,506.882,510.878,512.759,515.261,519.761,521.642,529.643,534.143,538.643,541.145,545.645" svgx:width="0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.33,0.78,0.44,0.44,0.5,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.5,0.25,0.89,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">demonstrated improvement (mean change from baseline to Month </text>
   <text y="543.899" x="310.016,314.516,316.766,318.152,321.149,326.153,332.651,335.648,338.645,340.895,342.281,344.783,349.283,351.533,352.919,360.92,365.924,368.921,373.925,376.922,381.422,385.922,388.172,389.558,394.058,398.558,403.058,406.559,409.061,413.057,417.053,419.555,421.805,423.191,426.692,431.192,435.692,439.193,443.189,447.185,449.687,453.683,455.933,457.319,460.316,463.313,467.813,472.313,474.563,479.063,483.563,485.813,487.199,490.196,494.696,499.196,501.446,505.946,510.446,513.443,515.945,518.195,519.581,524.081,529.157,533.657,538.157,542.657,545.654" svgx:width="0.5,0.25,0.55,0.33,0.56,0.72,0.33,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.33,0.56,0.33,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.39,0.28,0.44,0.44,0.28,0.25,0.55,0.39,0.5,0.5,0.39,0.44,0.44,0.28,0.44,0.25,0.55,0.33,0.33,0.5,0.5,0.25,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.25,0.5,0.5,0.33,0.28,0.25,0.55,0.5,0.56,0.5,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">6 [SD]) in MSIS-29 physical subscale (-10.06 [18.16]; n=218) </text>
   <text y="554.897" x="310.016,314.012,318.512,325.514,330.014,334.01,337.007,341.003,345.503,347.51,354.008,356.51,359.012,363.512,365.519,370.019,374.015,376.517,379.019,383.015,387.515,390.017,393.518,395.525,400.025,402.86,405.857,407.864,410.366,413.363,417.359,421.355,423.857,430.859,434.855,439.355,441.857,443.864,446.861,449.858,454.358,456.608,461.108,465.608,467.615,470.612,475.112,479.612,481.862,486.362,490.862,493.859,496.361,498.368,502.868,507.944,512.444,516.944,519.941,522.191,524.198,530.201,536.699,539.696,542.693,545.69" svgx:width="0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.33,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.33,0.33,0.5,0.25,0.5,0.5,0.25,0.33,0.5,0.5,0.25,0.5,0.5,0.33,0.28,0.25,0.5,0.56,0.5,0.5,0.33,0.25,0.25,0.67,0.72,0.33,0.33,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">compared with patients off treatment (-1.10 [17.03]; n=85). CGI-I </text>
   <text y="565.895" x="310.016,313.517,317.513,322.013,325.01,329.006,332.507,334.325,336.827,343.829,348.329,351.326,355.826,360.326,364.322,368.822,370.64,373.142,377.642,379.46,383.96,388.46,395.957,398.207,400.025,403.022,407.018,414.02,418.016,420.518,425.018,429.014,433.514,435.332,438.833,441.335,445.331,449.831,452.333,456.329,458.147,460.649,465.149,466.967,471.467,475.967,483.464,485.714,487.532,491.528,496.028,500.528,502.346,508.844,513.344,516.341,519.842,523.838,528.338,532.334,536.834,538.652,541.154,545.654" svgx:width="0.39,0.44,0.5,0.33,0.44,0.39,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.83,0.25,0.25,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.39,0.28,0.44,0.5,0.28,0.44,0.25,0.28,0.5,0.25,0.5,0.5,0.83,0.25,0.25,0.44,0.5,0.5,0.25,0.72,0.5,0.33,0.39,0.44,0.5,0.44,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">scores improved in 78%, remained stable in 14%, and worsened in </text>
   <text y="576.893" x="310.016,314.516,322.013,324.263,325.109,329.609,332.606,334.856,335.702,340.202,344.198,346.7,349.202,353.198,357.698,360.2,363.701,365.951,366.797,369.299,372.296,376.292,380.288,382.79,386.786,391.286,393.536,394.382,400.88,403.382,405.884,410.384,412.634,413.48,418.484,424.487,427.484,430.481,434.477,441.479,445.979,448.976,451.478,455.978,458.48,462.98,466.976,469.226,470.072,473.069,477.569,482.645,487.145,491.645,496.145,499.142,501.392,502.238,506.234,508.736,510.986,511.832,519.833,524.333,528.833,531.335,535.835,538.085,538.931,543.431,545.681" svgx:width="0.5,0.83,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.56,0.67,0.33,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.56,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.28,0.25,0.55,0.89,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">8% of patients treated with PR-fampridine (n=172) at Month 6, </text>
   <text y="587.891" x="310.016,314.012,318.512,325.514,330.014,334.01,337.007,341.003,345.503,347.753,349.904,356.402,358.904,361.406,365.906,368.156,370.307,374.807,379.307,386.804,389.054,391.304,393.455,397.955,402.455,409.952,412.202,414.353,418.349,422.849,427.349,429.599,431.75,436.25,440.75,448.247,450.497,452.648,457.148,460.145,462.395,464.546,469.046,473.042,475.544,478.046,482.042,486.542,489.044,492.545,494.795,496.946,501.446,504.281,507.278,509.528,511.679,514.181,517.178,521.174,525.17,527.672,534.674,538.67,543.17,545.672" svgx:width="0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.5,0.83,0.25,0.25,0.55,0.5,0.5,0.83,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.83,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.33,0.33,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">compared with 14%, 63% and 24% of patients off treatment </text>
   <text y="598.889" x="310.016,313.013,317.513,322.589,327.089,331.589,334.586,336.836,339.086,341.885,344.882,348.878,352.379,356.879,360.875,364.871,367.373,369.875,374.375,378.371,380.873,384.788,387.038,389.288,391.925,397.424,401.924,405.92,408.17,410.969,417.971,422.471,425.972,428.474,430.724,433.523,437.519,442.019,449.021,456.023,460.523,465.023,467.273,469.577,476.075,481.574,485.075,487.325,490.124,496.622,500.618,503.615,507.611,509.861,512.66,515.162,519.662,523.163,527.663,534.665,539.165,541.667,545.663" svgx:width="0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.25,0.55,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.78,0.5,0.39,0.28,0.25,0.55,0.44,0.5,0.78,0.78,0.5,0.5,0.25,0.55,0.72,0.61,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.28,0.5,0.39,0.5,0.78,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(n=80), respectively. The most common AEs were insomnia </text>
   <text y="609.887" x="310.016,313.013,317.513,322.589,327.089,331.589,333.839,335.522,338.519,343.019,350.516,353.513,356.51,358.76,361.01,362.693,367.193,371.189,375.185,379.685,383.681,387.677,392.177,396.173,398.423,400.106,403.103,407.603,412.679,417.179,421.679,423.929,425.612,428.609,433.109,440.606,443.603,446.6,448.85,451.1,452.783,456.779,461.279,465.779,468.029,469.712,474.212,478.208,481.205,483.707,486.209,490.709,495.209,497.459,499.142,502.139,506.639,511.715,516.215,520.715,522.965,524.648,527.645,532.145,539.642,542.639,545.636" svgx:width="0.33,0.5,0.56,0.5,0.5,0.25,0.55,0.33,0.5,0.83,0.33,0.33,0.25,0.25,0.55,0.5,0.44,0.44,0.5,0.44,0.44,0.5,0.44,0.25,0.55,0.33,0.5,0.56,0.5,0.5,0.25,0.55,0.33,0.5,0.83,0.33,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.56,0.5,0.5,0.25,0.55,0.33,0.5,0.83,0.33,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(n=68 [7%]), headache (n=38 [4%]), and vertigo (n=30 [3%]) </text>
   <text y="620.885" x="310.016,314.012,321.014,325.514,330.014,334.514,336.764,340.76,345.26,348.257,352.757,355.259,357.761,361.757,366.257,368.507,373.007,377.003,379.505,382.007,386.003,390.503,393.005,396.506" svgx:width="0.44,0.78,0.5,0.5,0.5,0.25,0.44,0.5,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">among enrolled patients.</text>
   <text y="631.883" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="631.883" x="368.561,374.06,377.057,383.06,388.559,394.562,400.061,405.56,411.059,413.309,420.086,422.588,427.088,429.59,433.586,436.583,439.085,446.087,448.337,455.123,459.623,463.619,466.121,470.117,472.367,479.153,483.653,487.649,494.651,499.151,503.651,507.152,509.654,512.651,516.647,519.149,523.145,525.395,532.172,534.674,539.174,543.17,545.672" svgx:width="0.61,0.33,0.67,0.61,0.67,0.72,0.61,0.61,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.28,0.78,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">LIBERATE interim data demonstrate that </text>
   <text y="642.881" x="310.016,315.02,321.023,324.02,327.017,331.013,338.015,342.515,345.512,348.014,352.514,355.016,359.516,363.512,365.762,367.679,370.181,373.178,377.174,381.17,383.672,390.674,394.67,399.17,401.672,403.922,405.839,408.341,411.842,414.092,416.009,422.507,426.503,429.005,431.507,433.757,435.674,438.176,442.676,445.178,449.174,452.171,456.167,458.669,462.665,467.165,469.415,471.332,475.328,479.828,484.328,486.578,488.495,492.491,495.992,499.493,503.993,507.989,510.491,514.487,516.989,520.985,525.485,527.735,529.652,536.15,538.652,541.154,545.654" svgx:width="0.56,0.67,0.33,0.33,0.44,0.78,0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.39,0.25,0.55,0.72,0.44,0.28,0.28,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PR-fampridine treatment is well tolerated and associated with </text>
   <text y="653.879" x="310.016,312.518,319.52,324.02,327.017,331.517,336.017,340.013,347.015,351.011,355.511,358.013,361.514,363.962,366.464,370.964,373.412,379.91,384.41,389.576,392.024,399.026,403.022,407.018,410.519,415.019,418.016,422.012,425.513,427.961,432.461,436.961,440.957,443.954,446.402,450.902,453.899,460.901,465.401,469.901,472.403,476.903,480.404,482.852,485.354,489.854,492.302,496.298,498.746,501.743,506.243,510.743,513.245,515.747,520.247,524.243,526.691,530.687,533.189,535.691,540.191,542.693" svgx:width="0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.25,0.72,0.5,0.61,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.39,0.25,0.5,0.5,0.44,0.33,0.25,0.5,0.33,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.28,0.5,0.25,0.44,0.25,0.33,0.5,0.5,0.28,0.28,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">improvements in QoL measures over 6-months in a routine clini-</text>
   <text y="664.877" x="310.016,314.012,318.008,320.51,322.76,327.26,330.257,334.253,338.249,340.751,343.253,347.249,351.245,353.495,355.997,360.497,362.747,367.751,370.748,374.744,379.244,383.24,387.236" svgx:width="0.44,0.44,0.28,0.25,0.5,0.33,0.44,0.44,0.28,0.28,0.44,0.44,0.25,0.28,0.5,0.25,0.56,0.33,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cal practice in France.</text>
   <text y="691.877" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P925</text>
   <text y="702.875" x="310.016,315.02,320.024,324.02,328.016,330.518,335.018,337.52,339.77,343.766,348.77,353.27,355.772,358.274,362.27,367.274,371.774,375.77,379.271,381.521,386.021,389.018,391.268,396.272,400.268,405.272,409.268,413.768,416.018,421.022,425.522,428.024,430.526,433.028,437.528,440.525,443.027,447.527,451.523,453.773,457.769,462.269,466.265,470.261,472.511,475.013,480.017,482.267,489.764,494.768,497.27,500.267,502.769,507.773,510.275,514.271" svgx:width="0.56,0.56,0.44,0.44,0.28,0.5,0.28,0.25,0.44,0.56,0.5,0.28,0.28,0.44,0.56,0.5,0.44,0.39,0.25,0.5,0.33,0.25,0.56,0.44,0.56,0.44,0.5,0.25,0.56,0.5,0.28,0.28,0.28,0.5,0.33,0.28,0.5,0.44,0.25,0.44,0.5,0.44,0.44,0.25,0.28,0.56,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Special challenges of neuro palliative care in multiple </text>
   <text y="713.873" x="310.016,313.517,317.513,320.015,324.011,328.007,332.507,336.008,338.51,342.011,344.261,349.265,353.765,356.762,359.264,363.26,368.264,371.261" svgx:width="0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">sclerosis patients</text>
   <text y="724.871" x="310.016,313.517,315.767,322.265,326.765,330.761,335.261,337.763,341.759" svgx:width="0.39,0.25,0.72,0.5,0.44,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">J Koehler</text>
   <text y="722.439" x="344.755" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="724.959" x="347.68,349.93,352.18,358.678,360.928,366.427,368.929,373.429,377.929,381.925,386.425" svgx:width="0.25,0.25,0.72,0.25,0.61,0.28,0.5,0.5,0.44,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Lindena</text>
   <text y="722.439" x="390.421" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="724.959" x="393.346,395.596,397.846,403.849,406.099,412.102,416.098,419.599,423.595,428.095,432.595,439.093,442.09,448.093,452.089,454.591,461.089,463.591,467.587" svgx:width="0.25,0.25,0.67,0.25,0.67,0.44,0.39,0.44,0.5,0.5,0.72,0.33,0.67,0.44,0.28,0.72,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, B Basedow-Rajwich</text>
   <text y="722.439" x="472.086" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="724.959" x="475.011,477.261,479.511,486.009,492.507,497.511" svgx:width="0.25,0.25,0.72,0.72,0.56,0.61" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, HOPE</text>
  </g>
 </g>
</svg>
